Could cardiovescular risk nomogram be supirior than the Framingham Risk Score? If so, what could be the reasons?


0

57

September 20, 2022

Background to PFS endpoint


18

2176

September 18, 2022

Elastic net model for nonlinear relationship?


2

809

July 26, 2022

Intervention with early survival benefit, questionable long term harm


8

1452

May 26, 2022

Schoenfeld Residuals


1

803

May 23, 2022

Comparing nonnested models on the same data


4

1141

May 13, 2022

Should I impute persontime before conducting proportional hazards analysis?


7

1273

May 8, 2022

Stratification on a variable involved in an interaction term


3

944

May 4, 2022

Validation of cox model


4

2469

May 2, 2022

Cutpoint for Estimation of Prognostic value of a continuous Marker


5

1342

May 2, 2022

How should I compare crossing survival curves?


5

1355

April 28, 2022

Is logistic regression or survival analysis most appropriate in this case?


1

918

April 28, 2022

Statistical power estimation for a timedependent covariate in Cox (proportional hazards) regression


0

824

April 19, 2022

Propensity score weighting and competing risks


2

933

March 30, 2022

How to calculate number of events in each treatment arm given hazard ratio and CI?


2

1128

March 6, 2022

RMS Case Study in Cox Regression


1

8787

September 17, 2021

Hazard ratio plots with nonlinear & timevarying effects in R


28

27330

September 19, 2020

How to use RCS in mixed effects cox regression


3

1604

December 10, 2021

KaplanMeier: SE for absolute difference in timepoint survival


13

2271

October 30, 2021

How can I determined the best cutoff for survival ROC


1

1588

October 10, 2021

First RCT of Lopinavir–Ritonavir on SARSCoV2


38

14736

October 8, 2021

Overall survival vs diseasefree survival and other surrogate endpoints


2

3843

September 22, 2021

RMS Case Study in Parametric Survival Modeling


0

7300

September 17, 2021

What is the best way to establish correlation between two timetoevent analysis?


6

2142

September 13, 2021

How to handle MNAR from a covariate due to witnessing the survival outcome?


2

1447

September 10, 2021

Cox regression vs. competing risk regression?


9

3007

August 23, 2021

Probability in state Ps(t) and Hazard ratio HR in Cox model


1

1703

August 21, 2021

Restricted mean survival time and comparing treatments under nonproportional hazards


6

4402

August 10, 2021

Metaanalysis of timetoevent data for single group design


5

2254

June 17, 2021

Calculation of Sample Size for Survival: Logrank vs. Cox with covariates


2

1893

June 17, 2021
